换一批
换一批Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.
作者：
Huntington Study Group [1]
;
Samuel,Frank [2]
;
Claudia M,Testa [3]
;
David,Stamler [4]
;
Elise,Kayson [5]
;
Charles,Davis [6]
;
Mary C,Edmondson [7]
;
Shari,Kinel [8]
;
Blair,Leavitt [9]
;
David,Oakes [10]
;
Christine,O'Neill [11]
;
Christina,Vaughan [4]
;
Jody,Goldstein [4]
;
Margaret,Herzog [4]
;
Victoria,Snively [4]
;
Jacquelyn,Whaley [3]
;
Cynthia,Wong [12]
;
Greg,Suter [13]
;
Joseph,Jankovic [13]
;
Joohi,Jimenez-Shahed [13]
;
Christine,Hunter [14]
;
Daniel O,Claassen [14]
;
Olivia C,Roman [15]
;
Victor,Sung [15]
;
Jenna,Smith [16]
;
Sarah,Janicki [16]
;
Ronda,Clouse [17]
;
Marie,Saint-Hilaire [17]
;
Anna,Hohler [17]
;
Denyse,Turpin [17]
;
Raymond C,James [18]
;
Ramon,Rodriguez [18]
;
Kyle,Rizer [19]
;
Karen E,Anderson [19]
;
Hope,Heller [16]
;
Alexis,Carlson [20]
;
Susan,Criswell [20]
;
Brad A,Racette [21]
;
Fredy J,Revilla [22]
;
Frederick,Nucifora [22]
;
Russell L,Margolis [22]
;
MaryJane,Ong [23]
;
Tilak,Mendis [23]
;
Neila,Mendis [24]
;
Carlos,Singer [24]
;
Monica,Quesada [25]
;
Jane S,Paulsen [25]
;
Thomas,Brashers-Krug [25]
;
Amanda,Miller [25]
;
Jane,Kerr [26]
;
Richard M,Dubinsky [26]
;
Carolyn,Gray [27]
;
Stewart A,Factor [27]
;
Elaine,Sperin [28]
;
Eric,Molho [28]
;
Mary,Eglow [28]
;
Sharon,Evans [29]
;
Rajeev,Kumar [29]
;
Christina,Reeves [30]
;
Ali,Samii [31]
;
Sylvain,Chouinard [32]
;
Monica,Beland [6]
;
Burton L,Scott [6]
;
Patrick T,Hickey [33]
;
Sherali,Esmail [34]
;
Wai Lun Alan,Fung [35]
;
Clare,Gibbons [33]
;
Lina,Qi [36]
;
Amy,Colcher [36]
;
Cory,Hackmyer [36]
;
Andrew,McGarry [37]
;
Kevin,Klos [38]
;
Mark,Gudesblatt [38]
;
Lori,Fafard [38]
;
Laura,Graffitti [39]
;
Daniel P,Schneider [40]
;
Rohit,Dhall [41]
;
Joanne M,Wojcieszek [42]
;
Kathrin,LaFaver [43]
;
Andrew,Duker [43]
;
Erin,Neefus [43]
;
Hilary,Wilson-Perez [44]
;
David,Shprecher [45]
;
Paola,Wall [45]
;
Karen A,Blindauer [45]
;
Lynn,Wheeler [46]
;
James T,Boyd [46]
;
Emily,Houston [47]
;
Eric S,Farbman [48]
;
Pinky,Agarwal [9]
;
Shirley W,Eberly [9]
;
Arthur,Watts [49]
;
Pierre N,Tariot [50]
;
Andrew,Feigin [51]
;
Scott,Evans [9]
;
Chris,Beck [9]
;
Constance,Orme [9]
;
Jon,Edicola [51]
;
Emily,Christopher
作者单位：
Harvard Medical School, Boston, Massachusetts.
[1]
Virginia Commonwealth University, Richmond, Virginia.
[2]
Teva Pharmaceuticals Ltd, Frazer, Pennsylvania.
[3]
Center for Human Experimental Therapeutics, University of Rochester, Rochester, New York.
[4]
CSD Biostatistics, Tucson, Arizona.
[5]
Duke University, Durham, North Carolina.
[6]
Huntington Study Group, Rochester, New York.
[7]
Centre of Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, Canada.
[8]
University of Rochester, Rochester, New York.
[9]
Wake Forest School of Medicine, Winston-Salem, North Carolina.
[10]
Medical University of South Carolina, Charleston, South Carolina.
[11]
Hereditary Neurological Disease Centre, Wichita, Kansas.
[12]
Baylor College of Medicine, Houston, Texas.
[13]
Vanderbilt University Medical Center, Nashville, Tennessee.
[14]
University of Alabama School of Medicine, Birmingham, Alabama.
[15]
Columbia University, New York, New York.
[16]
Boston University Medical Campus, Boston, Massachusetts.
[17]
University of Florida College of Medicine, Gainesville, Florida.
[18]
Georgetown University, Washington, DC.
[19]
Washington University School of Medicine, St Louis, Missouri.
[20]
Greenville Health System, Greenville, South Carolina22University of South Carolina Medical School, Greenville, South Carolina.
[21]
Johns Hopkins University School of Medicine, Baltimore, Maryland.
[22]
Ottowa Parkinson's and Neurodegenerative Disorders Clinic, Ottawa, Canada.
[23]
University of Miami Health, Miami, Florida.
[24]
University of Iowa Carver College of Medicine, Iowa City, Iowa.
[25]
University of Kansas Medical Center, Kansas City.
[26]
Emory University, Atlanta, Georgia.
[27]
Albany Medical College, Albany, New York.
[28]
Rocky Mountain Movement Disorders Center, Englewood, Colorado.
[29]
University of Washington, Seattle, Washington.
[30]
Centre hospitalier de l'Université de Montréal, Montreal, Québec, Canada.
[31]
Hôpital Notre-Dame, Montréal, Québec, Canada.
[32]
North York General Hospital, Toronto, Canada.
[33]
North York General Hospital, Toronto, Canada35University of Toronto, Toronto, Ontario, Canada36Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada.
[34]
North York General Hospital, Toronto, Canada35University of Toronto, Toronto, Ontario, Canada.
[35]
Cooper University Hospital, Camden, New Jersey.
[36]
The Movement Disorders Clinic Oklahoma, Tulsa.
[37]
South Shore Neurologic Associates, Islip, New York.
[38]
Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
[39]
Parkinson's Institute and Clinical Center, Sunnyvale, California.
[40]
Indiana University School of Medicine, Indianapolis.
[41]
University of Louisville, Louisville, Kentucky.
[42]
University of Cincinnati, Cincinnati, Ohio.
[43]
University of Utah Health Care, Salt Lake City, Utah46Banner Sun Health Research Institute, Sun City, Arizona.
[44]
Medical College of Wisconsin, Milwaukee, Wisconsin.
[45]
University of Vermont Medical Center, Burlington, Vermont.
[46]
University of Nevada School of Medicine, Reno, Nevada.
[47]
Evergreen Neuroscience Institute, Kirkland, Washington.
[48]
Banner Alzheimer's Institute, Phoenix, Arizona.
[49]
Feinstein Institute for Medical Research, Manhasset, New York.
[50]
Harvard University, Boston, Massachusetts.
[51]
主题词
肾上腺素能摄取抑制剂(Adrenergic Uptake Inhibitors);舞蹈症(Chorea);细胞色素P450 CYP2D6(Cytochrome P-450 CYP2D6);双盲法(Double-Blind Method);用药计划表(Drug Administration Schedule);女(雌)性(Female);人类(Humans);杭廷顿病(Huntington Disease);男(雄)性(Male);中年人(Middle Aged);丁苯那嗪(Tetrabenazine);治疗结果(Treatment Outcome)
DOI
10.1001/jama.2016.8655
PMID
27380342
发布时间
2023-01-21
- 浏览25
JAMA
JAMA
40-50页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
